
Migrab IT 20mg/150mg Capsule SR
Marketer
Novalab Healthcare Pvt Ltd
Salt Composition
Rabeprazole (20mg) + Itopride (150mg)
Overview Migrab IT 20mg/150mg Capsule SR
Gastro-esophageal reflux disease (GERD) and peptic ulcers are effectively managed with the combined-action medication, Migrab IT 20mg/150mg SR Capsules. This formulation alleviates acidity symptoms like heartburn, stomach upset, and pain by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Migrab IT 20mg/150mg SR Capsules are determined by your physician and should be followed precisely, regardless of food intake. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is crucial due to potential interactions. Common, typically transient side effects include abdominal pain, bowel irregularities (diarrhea or constipation), headache, gas, fatigue, and increased salivation. Report any concerning side effects immediately. Drowsiness and dizziness are possible; refrain from operating machinery or engaging in activities requiring alertness until the medication's effects are understood. Alcohol consumption should be avoided due to increased sedation risk. Lifestyle adjustments, such as consuming cool milk and avoiding stimulants like caffeine and spicy foods, can enhance treatment efficacy. Prior to commencing Migrab IT 20mg/150mg SR Capsules, inform your doctor of any liver conditions, pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Migrab IT 20mg/150mg Capsule SR
There is no text provided to rephrase.
Uses of Migrab IT 20mg/150mg Capsule SR
Heartburn and ulcers (GERD and PUD)
Major Benefits of Migrab IT 20mg/150mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire capsule without chewing, crushing, or breaking it. Migrab IT 20mg/150mg sustained-release capsules should be taken on an empty stomach.
Common Side effects of Migrab IT 20mg/150mg Capsule SR:
- Stomach pain
- Diarrhea
- Constipation
- Headache
- Dizziness
- Flatulence
- Weakness
- Flu-like symptoms
- Increased saliva production
How to use Migrab IT 20mg/150mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire capsule without chewing, crushing, or dividing it. Administer Migrab IT 20mg/150mg Sustained-Release Capsules on an empty stomach.
How Migrab IT 20mg/150mg Capsule SR works:
Migrab IT SR capsules (20mg/150mg) combine rabeprazole, a proton pump inhibitor (PPI) that lessens stomach acid production for heartburn and indigestion relief, with itopride, a prokinetic agent. Itopride targets brain regions regulating emesis and enhances upper gastrointestinal motility, facilitating smoother food passage.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Migrab IT 20mg/150mg SR capsules should be approached with care. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Migrab IT 20mg/150mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Migrab IT 20mg/150mg sustained-release capsules with breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Migrab IT 20mg/150mg SR capsules may cause drowsiness, blurred vision, and dizziness, potentially reducing alertness. Driving is discouraged if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Migrab IT 20mg/150mg sustained-release capsules in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
For individuals with severe hepatic impairment, Migrab IT 20mg/150mg sustained-release capsules require careful administration. Dosage modification of Migrab IT 20mg/150mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Migrab IT 20mg/150mg Capsule SR :
Should you forget a Migrab IT 20mg/150mg Capsule SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Migrab IT 20mg/150mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
